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Background: Mycobacterium tuberculosis (M. 
tb) survives within the host by modulating host 
immune responses.  
Results: RD-1/ESAT-6 from M. tb induces IL-
1β in dendritic cells to direct Th2-
differentiation, which facilitates disease 
progression by inhibiting host protective Th1-
responses. 
Conclusion: Cytokines produced by M. tb-
infected cells play a role in promoting Th2-
responses to subvert host immunity. 
Significance: These findings contribute to 
understanding the immune-evasion mechanisms 
of M. tb. 
 
Abstract: 
 
Mycobacterium tuberculosis (M. tb), the 
causative agent of tuberculosis (TB), resides and 
replicates within phagocytes and persists in 
susceptible hosts by modulating protective 
innate immune responses. Furthermore, M. tb 
promotes T helper 2 (Th2) immune responses by 
altering the balance of T cell polarising 
cytokines in infected cells. However, cytokines 
that regulate Th2 cell differentiation during TB 
infection remain unknown. Here we show that 
IL-1β, produced by phagocytes infected by 
virulent M. tb strain H37Rv, directs Th2 cell 
differentiation. In sharp contrast, the vaccine 
strain BCG as well as RD-1 and ESAT-6 
mutants of H37Rv failed to induce IL-1β and 
promote Th2 cell differentiation. Furthermore, 
ESAT-6 induced IL-1β production in dendritic 
cells (DCs), and CD4+ T cells co-cultured with 
infected DCs differentiated into Th2 cells. 
Taken together, our findings indicate that IL-1β 
induced by RD-1/ESAT-6 plays an important 
role in the differentiation of Th2 cells, which in 
turn facilitates progression of TB by inhibiting 
host protective Th1 responses. 
 
Introduction: 
 
Tuberculosis (TB) is a global health problem 
that causes over nine million new cases and 
claims two million lives each year (1). 
According to the world health organization 
(WHO), nearly 2 billion people or nearly one 
third of the global population is latently infected 
with Mycobacterium tuberculosis (M. tb), the 
etiologica agent of TB (2). Current therapy for 
TB is lengthy and consists of multiple 
antibiotics, which have the risk of generating 
drug-resistant variants of M. tb (3-5). In fact, 
almost all countries, irrespective of their socio-
economic status, are now under threat from 
multiple drug resistant (MDR) and extensively 
drug resistant (XDR) stains of M. tb (3, 5, 6). 
Unfortunately, the rate by which new drug-
resistant variants of this deadly organism are 
generated is much faster than the rate by which 
new generation antibiotics are being discovered, 
which has already resulted in the appearance of 
totally drug resistant (TDR) TB strains (7, 8). 
Therefore, alternative treatment methods that 
avoid the generation of MDR strains are 
urgently needed. Immunotherapy is one possible 
option that might avoid such risks.  
 It has been well-established that T 
helper 1 (Th1) cells producing interferon (IFN)-
γ play a central role in host resistance to M. tb 
infection (9, 10). Consequently, interleukin (IL)-
12-, IL-12 receptor (IL-12R)-, signal transducer 
of activation and transcription (STAT)-4-, and 
T-bet-deficient animals, which are defective in 
the generation of T helper 1 (Th1) responses, are 
highly susceptible to M. tb infection (9, 11). 
Similarly, individuals with mutations in IL-12 or 
its signalling components are highly susceptible 
to M. tb infection (12, 13). It has been well-
documented that M. tb inhibits Th1 cells by 
inhibiting IL-12 production in infected cells 
(14). On the other hand, transfroming growth 
factor (TGF)-β produced by the infected cells 
directs the differentiation of induced regulatory 
T cells (iTregs) (15-17). In fact, it has been 
shown that iTregs are induced during the 
progression of TB, and this is associated with 
inhibition of protective T cell responses in the 
host (18, 19). M. tb infected cells also produce 
IL-6, which, in combination with TGF-β, 
provides favourable conditions for the 
differentiation of Th17 cells (20, 21). All Th cell 
subsets, including Th1 cells, Th2 cells, Th17 
cells, and Tregs are in a dynamic balance, and it 
has been therefore assumed that impaired Th1 
responses during the progression of TB are 
associated with increased Th2 responses. 
However, the cytokines produced by the 
infected cells that play a role in the development 
of Th2 responses during progression of TB have 
not been identified.  
 It has previously been shown that M. tb 
infected macrophages produce copious amounts 
of IL-1β (22, 23). IL-1β plays an important role 
in the differentiation of Th2 cells (24). Thus, we 
examined whether IL-1β produced by infected 
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phagocytes is responsible for Th2 cell 
differentiation during progression of TB. We 
observed that dendritic cells (DCs) infected with 
the virulent M. tb strain H37Rv induced copious 
amounts of IL-1β, whereas the vaccine strain 
Baccille Calmette Guérin (BCG) and M. tb 
strains carrying mutations in the region of 
difference (RD)-1 (H37RvΔRD-1) or early 
secretory antigenic target (ESAT)-6 
(H37RvΔESAT-6) failed to induce IL-1β. 
Importantly, complementation of 
H37RvΔESAT-6 with ESAT-6 restored IL-1β 
production in DCs. On the other hand, H37Rv, 
BCG and all H37Rv mutants induced 
comparable amounts of IL-12. H37Rv infected 
DCs induced both IFN-γ- and IL-4-producing 
CD4+ T cells, whereas BCG, H37RvΔRD-1, and 
H37RvΔESAT-6 selectively induced IFN-γ-
producing cells. We confirmed these findings by 
adoptive transfer experiments with naive CD4+ 
T cells isolated from IL-1βR knockout mice. 
Taken together, our findings indicate that IL-1β 
produced by infected phagocytes plays an 
important role in Th2 cell differentiation during 
TB. 
 
Experimental Procedures: 
 
Ethics Statement- Animal experiments were 
performed according to the guidelines approved 
by the Institutional Animal Ethics Committee 
meeting held on 22nd November 2007 at ICGEB 
(approval ID; ICGEB/IAEC/IMM-13/2007), 
New Delhi, India and Department of 
Biotechnology (DBT) guidelines, Government 
of India. All mice used for experiments were 
ethically sacrificed by asphyxiation in carbon 
dioxide according to institutional and DBT 
regulations. 
Mice- C57BL/6 and OT-II T cell receptor (TCR) 
transgenic mice (6–8 wks of age) were initially 
purchased from The Jackson Laboratory, USA. 
IL-1βR-/- mice were purchased from the Jackson 
Laboratory, USA. All animals were 
subsequently bred and maintained in the animal 
facility of the International Centre for Genetic 
Engineering and Biotechnology (ICGEB), New 
Delhi, India. 
Bacteria- Mycobacterium tuberculosis strain 
H37Rv was a kind gift from the Colorado State 
University repository. BCG, H37RvΔRD-1, 
H37RvΔESAT-6 and ESAT-6-complemented 
H37RvΔESAT-6 were a kind gift from Prof. 
David Sherman (SBRI, Seattle, USA). All 
mycobacterial strains were grown in 7H9 
(Middlebrook, Difco™, USA) medium 
supplemented with 10% ADC (albumin, 
dextrose, and catalase; Difco™, USA) and with 
0.05% Tween 80 and 0.2% glycerol, and 
cultures were grown to mid-log phase. Aliquots 
of the cultures in 20% glycerol were preserved 
at -80oC and these cryo-preserved stocks were 
used for infections. 
Reagents- Luminex kits were purchased from 
Bio-Rad. GM-CSF and IL-4 were obtained from 
R&D Biosystems, USA. Purified anti-mouse IL-
1β antibody (clone B122) was purchased from 
e-Biosciences, USA. 
Generation of dendritic cells (DCs) - Mice were 
euthanized and the femurs were isolated. Bone 
marrow (BM) was flushed out with RPMI-1640 
medium using a 2.0 ml syringe (26.5G). The 
cells were washed twice with PBS and then 
cultured in complete RPMI-1640 (Gibco, UK) 
medium supplemented with granulocyte 
monocyte-colony stimulating factor (GM-CSF, 
40 ng/ml) and IL-4 (10 ng/ml) on 24-well plates 
(1 million cells/ml). On the third day, 75% of 
the medium was replaced with fresh DC culture 
medium. On day 5, the suspended cells were 
removed and the loosely adherent cells were 
collected as immature DCs (CD11c-positive 
cells were >90%). For mature DCs, immature 
DCs were stimulated with lipopolysaccharide 
(LPS, 1 μg/ml) for 24 hours. FACS analysis 
using anti-CD11c, -CD80, -CD86, and -MHC 
class II antibodies suggested that >95% of the 
cells were conventional DCs. 
Bacterial infections and co-culture of DCs with 
CD4+ T cells- In vitro: BM cells were isolated 
from mice (C57BL/6), differentiated into 
immature DCs as described above and cultured 
in 24-well plates (1x106 cells per well). Cells 
were infected with H37Rv, H37RvΔRD-1, 
BCG, H37RvΔESAT-6, or ESAT-6-
complemented H37RvΔESAT-6 (MOI of 1:10). 
Supernatants from cells were collected at 24, 48 
and 72 hrs for cytokine profiling. For T cell 
differentiation, CD4+ T cells (1x106) were 
purified by magnetic activated cell sorting 
(MACS) method (CD4+ T cell isolation beads 
kit; Miltenyi Biotech, Germany) from OT-II 
TCR transgenic mice and co-cultured with 
immature DCs (1x106) infected with H37Rv, 
H37RvΔRD-1, BCG, H37RvΔESAT-6, or 
ESAT-6-complemented H37RvΔESAT-6 in the 
presence of ovalbumin (OVA) (10 μg/ml) 
peptide (Thermo Scientific, USA) for 72 hrs. 
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Then, CD4+ T cells were harvested and 
subjected to intracellular staining for IL-4 and 
IFN-γ expression. 
In vivo: Mice (C57BL/6) used for these 
experiments were infected with H37Rv, 
H37RvΔRD-1, H37RvΔESAT-6, BCG or 
ESAT-6-complemented H37RvΔESAT-6 
through the aerosol route. 
Detection of cytokines- Cytokines in the culture 
supernatant of DCs were assayed by a Luminex 
microbead-based multiplexed assay using 
commercially available kits according to the 
manufacturer’s protocol (BioPlex, Bio-Rad, 
USA). 
Antibody treatment- For depletion of IL-1β, we 
cultured cells in the presence of anti-IL-1β mAb 
(10 μg/ml) and collected the supernatant for 
cytokine profiling after different time points. 
T cell adoptive transfer- For adoptive transfer 
experiments, Thy1.1+ mice were gamma-
irradiated (8 rads/sec for 100 seconds) and 
rested for a day. CD4+ T cells, isolated from 
lymph nodes of IL-1R-/- mice (Thy1.2+ 
background) were then adoptively transferred 
into the irradiated recipient mice (2-4 X 106 
cells per mouse). After 15 days recipient mice 
were challenged with H37Rv through the 
aerosol route. 
Intracellular cytokine staining- For intracellular 
cytokine staining, cells were treated with 50 
ng/ml phorbol myristate acetate (PMA) and 500 
ng/ml ionomycin in the presence of 10 μg/ml 
brefeldin A (Sigma-Aldrich or eBiosciences, 
USA) added during the last 6 h of culture. Cells 
were washed twice with PBS and resuspended 
in a permeabilization buffer (Cytofix/Cytoperm 
kit; BD), and stained with the following 
fluorescently conjugated monoclonal antibodies: 
anti-CD4 (clone GK1.5)-allophycocyanin 
(APC), anti-IFN-γ (clone XMG1.2)-fluorescein 
isothiocyanate (FITC), anti-IFN-γ (clone 
XMG1.2)-APC, anti-IL-4 (clone GK1.5)-
phycoerythrin (PE) (eBiosciences, USA). 
Fluorescence intensity was measured by flow 
cytometry (FACS Calibur or FACS CantoII; 
BD) and data were analysed with FlowJo (Tree 
star, USA). 
Western Blot analysis- DCs derived from 
C57BL/6 mice were infected with H37Rv or 
H37RvΔESAT-6. For T cell differentiation, 
CD4+ T cells (1x106) were purified by MACS  
(CD4+ T cell isolation beads kit; Miltenyi 
Biotech, Germany) from OT-II TCR 
transgenic mice and co-cultured with DCs 
(1x106) infected with H37Rv or H37RvΔESAT-
6 in the presence of OVA-peptide (5 μg/ml). 
Whole cell lysate was prepared by using lysis 
buffer (50 mM Tris HCL pH 7.4, 5 mM EDTA, 
120 mM NaCl, 0.5% NP40, 0.5 mM NaF, 1 
mM dithiothreitol, 0.5 mM 
phenylmethylsulfonyl fluoride) along with 
HALTTM phosphatase inhibitor cocktail (78420 
Thermoscientific, USA) and protease inhibitor 
cocktail (78410 Thermoscientific, USA) for 1 
hr. Samples were electrophoresed on a 10% 
SDS-polyacrylamide gel and electroblotted 
onto polyvinylidene difluoride (PVDF) 
membranes. Blots were blocked for 1 hr in 5% 
BSA in PBST (PBS with 0.1% Tween-20). 
STAT6, pSTAT6, STAT4 and pSTAT4 proteins 
were detected with anti-STAT6 (Sc-621), -
pSTAT6 (Sc-11762-R), -STAT4 (Sc-486) and -
pSTAT4 (Sc-16317-R) polyclonal antibodies, 
respectively, at a dilution of 1:250 and as 
recommended by the manufacturer (SantaCruz 
Biotechnology, USA). Goat anti-rabbit-
immunoglobulin G–conjugated horseradish 
peroxidase (Sc-2004) (diluted 1:2500) was used 
as a secondary antibody (SantaCruz 
Biotechnology, USA). Immunoblotting for 
GAPDH was carried out to confirm equal 
loading. 
Statistical analysis- All data were derived from 
at least three independent experiments. 
Statistical analyses were conducted using 
SPSS10 software and values were presented as 
mean ± SD. Significant differences between the 
groups were determined by ANOVA followed 
by Tukey's multiple comparison test (SPSS 
software). A value of p<0.05 was accepted as an 
indication of statistical significance. 
 
Results: 
 
Virulent M. tb H37Rv but not BCG induces IL-
1β and Th2 cells. It is now well established that 
Th1 cell responses play a protective role (10) 
whereas Th2 and iTreg cells facilitate 
progression of TB (11, 18). Previous studies 
have provided evidence that BCG induces Th1 
cell responses (25), whereas virulent H37Rv 
induces both Th1 and Th2 cell responses (26). 
Despite adequate Th1 cell responses, M. tb 
continues to progress towards disease in 
susceptible hosts suggesting that Th1 immunity 
is not sufficient for optimal host protection. 
Differentiation of Th1 and Th2 subsets requires 
IL-12 and IL-4, respectively (14, 27). While IL-
 by guest on M
arch 15, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 5
12 produced by professional antigen presenting 
cells (APCs) drives Th1 cell differentiation (13), 
professional APCs do not produce IL-4. 
However, it has been shown that under some 
circumstances, IL-1β produced by APCs plays 
an important role in Th2 cell differentiation (28, 
29). Therefore, we determined the cytokines 
produced by M. tb or BCG infected DCs. We 
generated bone marrow-derived DCs from 
C57BL/6 mice and infected these cells with 
H37Rv or BCG. We determined the T cell 
polarizing cytokines IL-12 and IL-1β. We found 
that both H37Rv and BCG induced IL-12 
whereas only H37Rv induced IL-1β (Fig. 1A). 
We next determined whether these infected DCs 
differentially facilitate the differentiation of Th 
cells. To test this hypothesis, we co-cultured 
CD4+ T cells isolated from OT-II TCR Tg mice 
in the presence of OVA peptide. We observed 
that H37Rv infected DCs induced large amounts 
of both IFN-γ and IL-4, whereas BCG infected 
DCs induced only IFN-γ in T cells (Fig 1B). 
This observation suggests that M. tb induces 
either Th0 cells, which produce both IFN-γ and 
IL-4, or induce distinct populations of Th1 
(IFN-γ producers) and Th2 (IL-4 producers) 
cells. Therefore, to distinguish between these 
possibilities, we performed intracellular staining 
of CD4+ T cells for IFN-γ and IL-4 production. 
We found that H37Rv induced few if any CD4+ 
T cells producing both IFN-γ and IL-4 
simultaneously. In sharp contrast, BCG induced 
IFN-γ-producing cells only (Fig. 1C).  
RD-1/ESAT-6 induces IL-1β production and 
Th2 cell differentiation. From the preceding 
section it was clear that H37Rv induces both 
Th1 and Th2 responses, whereas BCG 
selectively induces Th1 responses. Compared 
with H37Rv, BGC lacks several genomic 
segments that are called regions of difference 
(RD), and a total of 22 such RD regions have 
been characterized. Among them, RD-1 has 
been shown to play an important role in the 
pathogenicity of M. tb and its capacity to 
subvert the immune system (30, 31). Therefore, 
we tested whether RD-1 has a role in inducing 
IL-1β in DCs and to promote Th2 cell 
responses. ESAT-6 and CFP-10 are two 
important antigenic proteins encoded within the 
RD-1 region that are secreted as a complex. 
Thus, mutation in either protein impairs 
formation and secretion of the complex (30, 32, 
33). Therefore, to understand the role of RD-1 
we performed experiments with deletion 
mutants of H37Rv in RD-1 (H37RvΔRD-1) or 
ESAT-6 (H37RvΔESAT-6). Interestingly, 
neither the H37RvΔRD-1 mutant nor the 
H37RvΔESAT-6 mutant was able to induce IL-
1β, whereas both mutants induced levels of IL-
12 comparable to H37Rv and BCG (Fig. 2A). 
Taken together, these observations indicated 
that the RD-1 region of H37Rv plays an 
important role in the production of IL-1β by 
infected DCs, but has little if any role in the 
production of IL-12 (Fig. 2A). Next we tested 
whether cytokines (and possibly IL-1β) 
produced by the H37Rv-infected DCs assist in 
the differentiation of Th2 cells. For this purpose, 
we co-cultured naïve CD4+ T cells from OT-II 
TCR Tg mice with infected DCs pulsed with 
OVA peptide. We determined cytokines 
produced in the culture supernatant as well as 
cytokines produced by the cells intracellularly. 
We found that DCs infected with H37Rv 
induced both IL-4- and IFN-γ-producing CD4+ T 
cells whereas BCG-infected DCs selectively 
induced IFN-γ-producing CD4+ T cells (Fig. 
2B). These observations clearly indicate that the 
RD-1 region of virulent strain H37Rv plays a 
dominant role in inducing Th2 responses. 
Neutralization of IL-1β abrogates Th2 cell 
differentiation in T cell co-cultures with infected 
DCs. To further investigate the role of IL-1β in 
Th2 cell differentiation induced by H37Rv, we 
performed T cell co-culture experiments with 
infected DCs in the presence of anti-IL-1β 
antibodies. Neutralization of IL-1β with 
antibody dramatically abrogated IL-4 
production by CD4+ T cells (Fig. 3A). 
Interestingly, DCs infected with BCG, 
H37RvΔRD-1 or H37RvΔESAT-6 mutants 
selectively induced IFN-γ production and this 
was not affected by anti-IL-1β antibodies, which 
thus served as a negative control (Fig. 3B). We 
also neutralized IL-1β in co-cultures of T cells 
with DCs infected with RD-1-complemented 
BCG. Similar to the results obtained for H37Rv, 
we found that neutralization of IL-1β 
dramatically abrogated Th2 cell differentiation 
induced by RD-1-complemented BCG. To 
confirm these findings, we investigated the 
molecular mechanism of Th cell differentiation 
in infected DCs co-cultured with T cells.  For 
this purpose, we performed Western blot 
analysis of STAT6, pSTAT6, STAT4 and 
pSTAT4 proteins in OT-II CD4+ T cells from 
cultures with infected DCs. We observed 
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phosphorylation of STAT-6 in CD4+ T cells co-
cultured with H37Rv infected DCs, and this 
was dramatically reduced when IL-1β was 
neutralized by antibodies (Fig. 3C). In 
contrast, CD4+ T cells co-cultured with 
H37RvΔESAT-6 were unable to induce STAT-
6 phosphorylation. We also examined STAT-4 
phosphorylation and found an opposite pattern 
(Fig. 3C). These data suggest that IL-1β plays 
an important role in Th2 cell polarization 
during M. tb infection, and that ESAT-6 or 
factors controlled by ESAT-6 are responsible 
for induction of IL-1β. 
Cytokine profiles in lungs of infected animals. 
Next, we complemented our in vitro finding 
showing that the RD-1 region of virulent strain 
H37Rv induces IL-1β to promote Th2 cell 
differentiation, with in vivo experiments. We 
also performed cytokine profiling studies of 
lung homogenates obtained from C57BL/6 mice 
infected with H37Rv, BCG or H37RvΔESAT-6. 
Consistent with our in vitro data, we observed 
that H37Rv infected animals produced both IL-4 
and IFN-γ, whereas BCG infected animals 
induced only IFN-γ at all time points analysed 
(Fig. 4A). To obtain further information about 
the relevant T cell differentiating cytokines, we 
determined the levels of IL-12 and IL-1β, as in 
our in vitro experiments. We detected both IL-
1β and IL-12 in lung homogenates from H37Rv-
infected mice, whereas BCG infected animals 
selectively produced IL-12, at levels similar to 
H37Rv infected animals (Fig. 4A). We also 
determined cytokines in the lung homogenates 
of animals infected with H37RvΔRD-1 or 
H37RvΔESAT-6. As expected, both groups of 
infected animals produced IL-12 and IFN-γ but 
not IL-1β in their lungs (Fig 4B). In contrast, 
RD-1 complemented BCG induced IL-12 as 
well as IL-1β, and both IFN-γ and IL-4 were 
present (Fig. 4B). Collectively these data 
indicate that the RD-1 region plays an important 
role in the induction of IL-1β by H37Rv-
infected DCs, which in turn drives Th2 cell 
differentiation.  
IL-1β directly acts on CD4+ T cells to promote 
Th2 cell differentiation during M. tb infection. 
To provide further evidence that IL-1β plays an 
important role in the differentiation of Th2 cells 
in M. tb infected animals, we isolated CD4+ T 
cells from congenic wild type Thy1.2 or IL-
1βR-/- Thy1.2 mice and adoptively transferred 
these cells into irradiated Thy1.1 congenic 
animals followed by infection with H37Rv. 
Thirty days after infection, spleen cells from 
these animals were isolated and challenged with 
H37Rv complete soluble antigen (CSA) ex vivo, 
and we stained T cells for the intracellular 
cytokines IL-4 and IFN-γ. Cytokines produced 
by adoptively transferred CD4+ T cells were 
determined by gating on Thy1.2. We observed 
that CD4+ T cells from wild type animals had 
adopted a phenotype characterized by IFN-γ or 
IL-4 production. In contrast, CD4+ T cells from 
IL-1βR-/- mice predominantly differentiated into 
IFN-γ-producing cells (Fig. 5). Therefore, we 
conclude that IL-1β produced during the 
progression of TB disease is responsible for the 
generation of Th2 cell responses.  
 
Discussion: 
 
M. tb survives within susceptible hosts by 
altering host protective Th cell responses. IFN-
γ−induced macrophage activation that results in 
the production of nitric oxide radicals is the key 
mechanism for elimination of the harboured 
pathogens. Thus, animals that are defective in 
the production of IL-12, inducible nitric oxide 
synthase (iNOS), IFN-γ, or proteins involved in 
their signalling pathways exhibit increased 
susceptibility to M. tb infection (34). However, 
M. tb successfully inhibits IL-12 production in 
susceptible hosts and thus inhibits the 
development of Th1 responses (35). In addition, 
it has clearly been shown that M. tb not only 
prevents Th1 responses, but also facilitates Th2 
responses (36), which counter regulate host 
protective Th1 responses. Phagocytes, the 
natural home for M. tb, are the predominant 
source of IL-12 that drives Th1 cell 
differentiation. In contrast, IL-4, the key 
cytokine required for the differentiation of Th2 
cells, is not produced by APCs. Thus, it is likely 
that another cytokine is involved in promoting 
Th2 cell differentiation during the progression 
of TB. Interestingly, previous studies have 
shown that IL-1β can act as a co-stimulatory 
factor for Th2 cells (29). Indeed, we found that 
IL-1β is induced by M. tb infected DCs. We 
further showed that IL-1β is directly involved in 
Th2 cell differentiation during M. tb infection. 
Therefore, it appears that M. tb ensures survival 
not only by directly inhibiting Th1 responses, 
but also indirectly by mounting Th2 responses. 
In fact, it has been reported that inhibition of 
Th2 responses or genetic deficiency in the 
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generation of Th2 responses confers partial 
resistance to M. tb infection (37).  
Previously, it has been shown that IL-1β-
mediated signalling plays an important role in 
host resistance to M. tb infection (22, 38). In 
fact, IL-1β- and IL-1βR-deficient animals have 
increased susceptibility to M. tb infection (39). 
Similarly, mice deficient in the IL-1β signalling 
adaptor molecule MyD88 are highly susceptible 
to M. tb infection (40). However, the precise 
nature of the host protective immune responses 
induced by IL-1β during M. tb infection is 
unclear. Our results demonstrate that IL-1β 
induces Th2 cell differentiation, which has been 
shown to promote progression of TB by 
inhibiting host protective Th1 responses (11). 
Therefore, IL-1β might originate two divergent 
immune responses: (i) IL-1β might induce the 
MyD88 signalling pathway to promote 
protective innate host immune responses; and 
(ii) IL-1β might have a direct role in the 
differentiation of Th2 cells, which counter-
regulates protective host adaptive immune 
responses. Therefore, it will be of future interest 
to delineate the conditions and mechanisms by 
which IL-1β elicits these divergent responses.  
Previously, we have shown that BCG, M. 
tb H37Rv, and mutant strains H37RvΔRD-1 and 
H37RvΔESAT-6 induce IL-12 in DCs in a toll-
like receptor (TLR)-2-independent but MyD88-
dependent manner (41), suggesting that 
production of IL-12 is independent of RD-1. In 
this report we have shown that IL-1β production 
is dependent on RD-1/ESAT-6. Thus, M. tb has 
at least two different sets of factors that control 
IL-12 and IL-1β production to modulate Th cell 
differentiation during the progression of TB. 
Furthermore, it is known that Tregs also assist in 
the progression of TB (19), whereas the role of 
Th17 cells remains unclear and might differ 
during primary and secondary infection (41). 
Taken together, these data indicate that Th1 
cells are protective whereas Th2 cells and Treg 
cells promote disease. These Th cell subsets are 
in a dynamic balance during M. tb infection. In 
this context, it has been recently shown that 
mycobacterial strains that can mount Th1 
responses but are defective in the induction of 
Th2 cells or Tregs exhibit dramatically 
increased vaccine efficacy (36, 42). Consistent 
with these observations, our recent data indicate 
that animals that are unable to mount Th2 cells 
and Tregs (Stat-6-/-TGF-βRIIDN mice) are 
completely resistant to M. tb infection 
(Bhattacharya et al., under review). Therefore, 
in future studies it will be interesting to identify 
the components that are responsible for the 
induction of Th2 cells and Tregs, which will 
enable us to design improved vaccines and 
therapies.  
In conclusion, we have demonstrated that 
the RD-1 region of M. tb is responsible for the 
capacity of this organism to promote Th2 cell 
differentiation. One of our future goals will be 
to identify the bacterial component(s) that 
induce(s) Tregs during TB disease. Our findings 
suggest that M. tb mutants that are defective in 
the induction of both Th2 cells and Tregs may 
serve as superior vaccines.  
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Legends to Figures: 
 
Figure 1. Capacity of M. tb strains to induce IL-1β secretion in DCs co-cultured with OT-II CD4+ 
T cells and to promote Th2 cell differentiation. (A) IL-12p40 and IL-1β levels after infection of DCs 
with H37Rv or BCG. IL-1β levels were significantly increased (p<0.01) in H37Rv infected DCs as 
compared with DCs infected with BCG. (B) IFN-γ and IL-4 levels after infection of DCs with H37Rv or 
BCG. IL-4 levels were significantly higher (p<0.01) in H37Rv infected DCs than BCG infected DCs. 
(C) Intracellular IFN-γ and IL-4 levels produced by CD4+ T cells from OT-II TCR transgenic mice co-
cultured with DCs infected with H37Rv or BCG. The results shown are representative of at least 3-4 
independent experiments. 
 
Figure 2. Cytokine profiling from DCs infected with H37Rv or mutant strains. (A) Measurements 
of levels of IL-12p40 and IL-1β from supernatants of DCs infected with H37Rv or mutant strains 
(H37RvΔRD1, H37RvΔESAT-6, or ESAT-6-complemented H37RvΔESAT-6) of H37Rv at different 
points. (B) Levels of IFN-γ and IL-4 from the culture supernatants of DCs infected with H37Rv or 
mutants (H37RvΔRD1, H37RvΔESAT-6, or ESAT-6-complemented H37RvΔESAT-6). H37Rv and 
ESAT-6-complemented H37RvΔESAT-6 (Comp-ESAT-6) direct differentiation of both Th1 (IL-12p40 
and IFN-γ) and Th2 (IL-4) cytokine responses as well as IL-1β production, whereas H37RvΔRD1 and 
H37RvΔESAT-6 induce only Th1 cytokines in infected DCs co-cultured with naïve OT-II CD4+ T cells. 
IL-4 and IL-1β levels were significantly increased (p<0.01) in H37Rv and Comp-ESAT-6 infected DCs 
as compared with DCs infected with the other strains. The results shown are representative of at least 
three independent experiments. 
 
Figure 3. ESAT-6 induces Th2 cell differentiation via IL-1β production. (A) IL-4 production in DCs 
co-cultured with naïve OT-II CD4+ T cells after infection with H37Rv or BCG in the presence or 
absence of anti-IL-1β. (B) IL-4 production in DCs co-cultured with naïve OT-II CD4+ T cells after 
infection with H37Rv or mutant strains (H37RvΔRD1, H37RvΔESAT-6 and Comp-ESAT-6) in 
the presence or absence of anti-IL-1β. IL-4 levels were higher in cultures with H37Rv or Comp-
ESAT-6 as compared with cultures with BCG or other mutant strains (p<0.003). (C) Western blot 
analysis of STAT6, pSTAT6, STAT4 and pSTAT4 proteins from DCs infected with H37Rv or 
H37RvΔESAT-6 and co-cultured with OT-II CD4+ T cells, to show modulated Th1 and Th2 responses 
in the presence or absence of anti-IL-1β. The results shown are representative of at least four 
independent experiments. 
 
Figure 4. H37Rv induces significantly higher Th2 responses and the proinflammatory cytokine 
IL-1β as compared with BCG or H37RvΔESAT-6. (A) Cytokine levels in lung homogenates of mice 
at different time points after infection with H37Rv or BCG. (B) Cytokine levels in lung homogenates of 
mice at different time points after infection with H37Rv or mutant strain H37RvΔESAT-6. Statistical 
significance between different strains was determined by one-way ANOVA: * p <0.01; ** p <0.017, 
*** p <0.001. The results shown are representative of at least three independent experiments with six 
mice within each group.  
 
Figure 5. IL-1β plays an important role in Th2 cell differentiation after infection with H37Rv 
without affecting Th1 cell differentiation. CD4+ T cells were isolated from congenic wild type Thy1.2 
or IL-1βR-/- Thy1.2 mice and adoptively transferred into irradiated Thy1.1 congenic animals followed 
by infection with H37Rv. Thirty days after infection, spleen cells from these animals were isolated and 
challenged with H37Rv complete soluble antigen (CSA) ex vivo. T cells were then stained for the 
intracellular cytokines IL-4 and IFN-γ. The results shown are representative of at least three independent 
experiments with three mice within each group.  
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